Literature DB >> 23158612

Fatal dabigatran toxicity secondary to acute renal failure.

Joseph K Maddry1, Mana Kouros Amir, Daniel Sessions, Kennon Heard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23158612     DOI： 10.1016/j.ajem.2012.08.015

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  8 in total

Review 1.  Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.

Authors:  Sascha Meyer Dos Santos; Sebastian Harder
Journal:  Drug Saf       Date:  2014-05       Impact factor: 5.606

Review 2.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 3.  Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors:  Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

Review 4.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

5.  Coagulopathy and Extremely Elevated PT/INR after Dabigatran Etexilate Use in a Patient with End-Stage Renal Disease.

Authors:  Joonseok Kim; Mrinal Yadava; In Chul An; Abrar Sayeed; Heather S Laird-Fick; Venu Gourineni; George S Abela
Journal:  Case Rep Med       Date:  2013-09-18

Review 6.  Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence.

Authors:  Kristine C Willett; Amanda M Morrill
Journal:  Ther Clin Risk Manag       Date:  2017-04-06       Impact factor: 2.423

7.  Assessment of novel oral anticoagulant use within a community teaching hospital.

Authors:  Sultan Alghadeer; Lori Hornsby
Journal:  Saudi Pharm J       Date:  2016-02-15       Impact factor: 4.330

8.  Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran.

Authors:  Kazunori Otsui; Diana A Gorog; Junichiro Yamamoto; Takayuki Yoshioka; Sachiyo Iwata; Atsushi Suzuki; Toru Ozawa; Asumi Takei; Nobutaka Inoue
Journal:  Thromb J       Date:  2015-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.